The Inflation Reduction Act Kicks Off Big Changes to Medicare Prescription Coverage

The Inflation Reduction Act (IRA) was signed into law in August 2022 and went into effect January 1, 2023. The IRA...

Read More

Four Strategies to Successfully Manage Specialty Medications

While specialty medications provide a new level of hope for people being treated for serious conditions such as...

Read More

Five Pipeline Developments to Watch in 2023

From biosimilars and COVID-19 to gene therapy and microbiomes, there are several developments in the pipeline to watch...

Read More

Looking Ahead to 2023: Medicare Readiness

The 2022 audit cycle is coming to a close. CMS issued its last engagement letters for 2022 program audits at the end of...

Read More

New Guidelines for Diabetes First Line Therapy Could Lead to Increases in Drug Spend

Diabetes is an epidemic that drives a significant amount of medical cost. Eleven percent of the United States’...

Read More

Elixir’s 2023 Formularies Drive Optimal Value with Under 1% Member Disruption

At Elixir, whole member health is at the heart of our formulary strategy and drug management practices. As we prepare...

Read More

Taking the Limits Out of Limited Distribution Drugs for Specialty Medication Access

Specialty medications are not only used to treat complex conditions, they are themselves complex in nature. Some have...

Read More

Inflation Reduction Act of 2022: The Basics

On August 16th, 2022, President Biden signed into law H.R. 5376, a budget reconciliation measure known as the Inflation...

Read More

What to Know for the 2022-2023 Flu Season

According to the Centers for Disease Control and Prevention (CDC), there were as many as 14,000 flu-related deaths and...

Read More

Is it Worth the Download: Digital Therapeutics' Place in Healthcare

Digital therapeutics (DTx) uses software programs to prevent, manage or treat diseases. They may be used with or...

Read More